Vivo Capital, LLC Delcath Systems, Inc. Transaction History
Vivo Capital, LLC
- $512 Million
- Q4 2024
A detailed history of Vivo Capital, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 1,708,579 shares of DCTH stock, worth $25.4 Million. This represents 3.93% of its overall portfolio holdings.
Number of Shares
1,708,579
Previous 997,005
71.37%
Holding current value
$25.4 Million
Previous $9 Million
123.58%
% of portfolio
3.93%
Previous 1.32%
Shares
6 transactions
Others Institutions Holding DCTH
# of Institutions
95Shares Held
11MCall Options Held
144KPut Options Held
57.4K-
Aigh Capital Management LLC Baltimore, MD1.39MShares$20.6 Million6.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$18.2 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT801KShares$11.9 Million0.66% of portfolio
-
Gilder Gagnon Howe & CO LLC New York, NY612KShares$9.11 Million0.08% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA419KShares$6.23 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $128M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...